FTC and FDA Take Action Against Unproven Diabetes Treatments

FTC and FDA Take Action Against Unproven Diabetes Treatments On September 9, 2021, the Federal Trade Commission (“FTC”) announced they teamed up with the U.S. Food and Drug Administration (“FDA”) to address concerns regarding companies advertising unproven treatments or cures for diabetes. The FTC issued cease-and-desist letters to 10 companies, including Ar-Rahmah Pharm, Aceva, and […]

Subscribe today to access the resources to help you stay compliant

CLIClaw Subscription

Professional

$500

Monthly
Annual Standard
Save $89/year

$499

Yearly
Standard

$49

Monthly

Continuous updates and additional resources will keep you ahead in compliance.

Unlock Your Compliance Solutions Now

With the new Professional Plan, you can gain everything included in the Standard CLIClaw Subscription – plus direct professional guidance from our legal compliance team each month.

Become a Professional Member Now:

Subscribe to Professional
Here you will find access to a collection of educational resources, customizable policies and practical solutions for your journey to knowledge empowerment. These proven materials used to design compliance programs for some of the largest marketers including online education, simplified guides, and checklists, as well as public resources, programs and outlines which are designed to assist you in creating your community of compliance.

Subscribe to the Standard Membership:

Subscribe Yearly
Subscribe Monthly

Stay Ahead of What's Coming Next

CLIClaw helps you see regulations early, understand what it means, and act before it becomes a problem. Members get plain-English analysis, practical guidance, and early warnings on privacy and compliance issues that directly impact your business. If you work with consumer data, waiting is the riskiest option.
Become a CLIClaw Member
JOIN TODAY